Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pilar, Garrido López"'
Autor:
Claudia Santucci, Beatriz González López-Valcarcel, Cristina Avendaño-Solá, Mari Carmen Bautista, Carmen Gallardo Pino, Lourdes Lledó García, Elena Martín-Perez, Pilar Garrido López
Publikováno v:
Human Resources for Health, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background The long-standing underrepresentation of women in leadership positions in medicine is well-known, but poorly documented globally. There is some evidence of the gender gap in academia, medical society leadership, or specific proble
Externí odkaz:
https://doaj.org/article/56fea65df6a04a7183564d9582f17b5a
Autor:
Magda Palka Kotlowska, Ana Gómez Rueda, María Eugenia Olmedo, Amparo Benito, Almudena Santón Roldán, Maria Angeles Fernandez Méndez, Luis Gorospe, José Palacios, Pilar Garrido López
Publikováno v:
Respiratory Medicine Case Reports, Vol 26, Iss , Pp 310-314 (2019)
Sarcomatoid carcinoma is a subtype of non-small cell lung cancer (NSCLC) characterized by mesenchymal – epithelial transition component and awful prognosis. In this report, based on a case of stage IV lung sarcomatoid carcinoma with an extraordinar
Externí odkaz:
https://doaj.org/article/eb95f1c5a22c490d89fd686ce6e84f65
Publikováno v:
Medicina Clínica (English Edition). 159:47-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::209db8eba34ebecf9461fc76ac83c0f4
https://doi.org/10.1016/j.medcle.2022.02.011
https://doi.org/10.1016/j.medcle.2022.02.011
Publikováno v:
Medicina Clínica. 159:47-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c55c2c8bfe67505986c2c49bf2ca64e2
https://doi.org/10.1016/j.medcli.2022.02.005
https://doi.org/10.1016/j.medcli.2022.02.005
Publikováno v:
Archivos de Bronconeumología. 56:380-389
Resumen En los ultimos anos la inmunoterapia (particularmente los inhibidores de los puntos de control inmunitario) ha suscitado un gran interes en el tratamiento de los pacientes con cancer de pulmon, revolucionando el manejo de los pacientes con tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6234c66ea36aebe4c10fe7b84f39c58
https://doi.org/10.1016/j.arbres.2019.10.023
https://doi.org/10.1016/j.arbres.2019.10.023
Publikováno v:
Medicina clinica. 159(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05889fb783c8f36586c5d92e5e37c5b0
https://pubmed.ncbi.nlm.nih.gov/35636993
https://pubmed.ncbi.nlm.nih.gov/35636993
Autor:
Luis Gorospe, María Eugenia Olmedo-García, Gemma María Muñoz-Molina, Pilar Garrido-López, María Eugenia Rioja-Martín, Laura Mezquita, Isabel García-Gómez-Muriel, Héctor Gerardo Pian-Arias, Joaquín Gómez-Ramírez
Publikováno v:
The Annals of Thoracic Surgery. 109:e397-e399
Pembrolizumab, a programmed death 1 inhibitor, has been shown to have clinically significant efficacy in different types of cancer, providing long-term survival benefit for patients with lung cancer. Herein, we report the development of a primary thy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7874f6062a7c33972a88f7ff98d2167d
https://doi.org/10.1016/j.athoracsur.2019.10.059
https://doi.org/10.1016/j.athoracsur.2019.10.059
Autor:
M. Phillip DeYoung, James Vasquez, Vladimir Kostorov, Sergey Orlov, David Bellovin, Pilar Garrido López, Evgeny Levchenko, Li Yan, Shirish M. Gadgeel, Hedy L. Kindler, Jose Manuel Trigo, Manuel Domine, Marjorie G. Zauderer, Jan H.M. Schellens, Dean A. Fennell, Xiaowei Wang, Katherine Baker-Neblett, Santiago Viteri, Daniel Morgensztern, Emilie M.J. van Brummelen, Johan Vansteenkiste, Ionel Mitrica
Publikováno v:
Invest New Drugs
BACKGROUND: Fibroblast growth factors (FGFs) have a fundamental role in cancer. Sequestering FGFs with GSK3052230 (FP-1039) blocks their ability to activate FGFRs while avoiding toxicities associated with small molecule inhibitors of FGFR, including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f79fa27ba3514b5c0a71da97b74f5a9
https://doi.org/10.1007/s10637-019-00783-7
https://doi.org/10.1007/s10637-019-00783-7
Publikováno v:
Archivos de bronconeumologia. 56(6)
Immunotherapy (particularly immune checkpoint inhibitors) in the treatment of patients with lung cancer has aroused great interest in recent years, revolutionized the management of patients with locally advanced/metastatic disease, and given hope to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c677e2cfbbd21c64d4e7c190baa16ba
https://pubmed.ncbi.nlm.nih.gov/31898993
https://pubmed.ncbi.nlm.nih.gov/31898993
Autor:
Ana María Ayala-Carbonero, Pilar Garrido-López, Gemma María Muñoz-Molina, Frank Eric Farfán-Leal, Luis Gorospe, Ana Gómez-Rueda, María Eugenia Olmedo-García
Publikováno v:
Surgery. 163(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60a3fb76065dfa7def451c932a76f72
https://pubmed.ncbi.nlm.nih.gov/28797547
https://pubmed.ncbi.nlm.nih.gov/28797547